Artemether Lumefantrine

Name: Artemether Lumefantrine
Brand: Artemisine Medicines Technology Co., Ltd.

Tablets

Artemether Lumefantrine — GMP manufactured tablets by Artemisine Medicines Technology. Original manufacturer supply with stable quality, factory direct price and full batch documentation for global markets.

Product Name	Artemether Lumefantrine
Dosage Form	Tablets
Strength	As per BP monograph / enterprise standard
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Tablets

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Uncomplicated Plasmodium falciparum malaria — WHO first-line artemisinin-based combination therapy (ACT).

💧Administration▾

Oral; take with fat-containing food or milk to maximise absorption. Doses at 0 and 8 hours, then twice daily for 2 more days.

⚖️Dosage▾

Adults and children ≥35 kg: 4 tablets (20/120 mg) per dose. 25–<35 kg: 3 tablets; 15–<25 kg: 2 tablets; 5–<15 kg: 1 tablet — each at 0 and 8 h, then twice daily on days 2 and 3.

⚠️Precautions & Warnings▾

Avoid in the first trimester of pregnancy. Caution with QT-prolonging drugs; common effects are headache, dizziness, palpitations and GI upset. Re-treat or refer if vomiting within 1 hour of a dose.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Artemether Lumefantrine — Frequently Asked Questions

Which documents are provided for Artemether Lumefantrine registration?

Every batch of Artemether Lumefantrine ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Artemether Lumefantrine?

MOQ and lead time for Artemether Lumefantrine depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Artemether Lumefantrine, subject to the regulatory requirements of the destination market.

Which markets have you exported tablets products to?

We have supplied tablets products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Artemether Lumefantrine controlled?

Artemether Lumefantrine is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›